From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases
Authors
Keywords
mRNA vaccines, miRNAs, siRNAs, Aptamers, Riboswitches
Journal
MOLECULAR ASPECTS OF MEDICINE
Volume -, Issue -, Pages 101003
Publisher
Elsevier BV
Online
2021-07-28
DOI
10.1016/j.mam.2021.101003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How COVID unlocked the power of RNA vaccines
- (2021) Elie Dolgin NATURE
- The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy
- (2021) Dominic Scaglioni et al. Acta Neuropathologica Communications
- Viral Vectors for COVID-19 Vaccine Development
- (2021) Kenneth Lundstrom Viruses-Basel
- Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies
- (2021) Sabrina Bochicchio et al. Pharmaceutics
- A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice
- (2021) Ruklanthi de Alwis et al. MOLECULAR THERAPY
- Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
- (2021) Sander F. Garrelfs et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
- (2021) Ioanna Gouni-Berthold et al. Lancet Diabetes & Endocrinology
- Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis
- (2020) Laura Obici et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Pharmacokinetics and Pharmacodynamics of the Small Interfering Ribonucleic Acid (siRNA), Givosiran, in Patients with Acute Hepatic Porphyria
- (2020) Sagar Agarwal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Golodirsen: First Approval
- (2020) Young-A Heo DRUGS
- Givosiran: First Approval
- (2020) Lesley J. Scott DRUGS
- Combination of RT‐qPCR Testing and Clinical Features For Diagnosis of COVID‐19 facilitates management of SARS‐CoV‐2 Outbreak
- (2020) Yishan Wang et al. JOURNAL OF MEDICAL VIROLOGY
- Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
- (2020) Diane E. Frank et al. NEUROLOGY
- Comparison of the efficacy of MOE and PMO modifications of systemic antisense oligonucleotides in a severe SMA mouse model
- (2020) Lei Sheng et al. NUCLEIC ACIDS RESEARCH
- RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
- (2020) Sarah Bajan et al. Cells
- Big Is Beautiful: Enhanced saRNA Delivery and Immunogenicity by a Higher Molecular Weight, Bioreducible, Cationic Polymer
- (2020) Anna K. Blakney et al. ACS Nano
- Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes
- (2020) Nuphar Veiga et al. ADVANCED DRUG DELIVERY REVIEWS
- Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
- (2020) Timothy R. Abbott et al. CELL
- A Mouse Model of SARS-CoV-2 Infection and Pathogenesis
- (2020) Shi-Hui Sun et al. Cell Host & Microbe
- Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a)
- (2020) Lotte C A Stiekema et al. EUROPEAN HEART JOURNAL
- RNA therapeutics on the rise
- (2020) Feng Wang et al. NATURE REVIEWS DRUG DISCOVERY
- Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
- (2020) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phosphorothioate modified oligonucleotide–protein interactions
- (2020) Stanley T Crooke et al. NUCLEIC ACIDS RESEARCH
- Former orphan riboswitches reveal unexplored areas of bacterial metabolism, signaling, and gene control processes
- (2020) Madeline E. Sherlock et al. RNA
- In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials
- (2020) Kurt Selle et al. mBio
- Investigating the Impact of Delivery System Design on the Efficacy of Self-Amplifying RNA Vaccines
- (2020) Giulia Anderluzzi et al. Vaccines
- Investigational Therapies for Primary Hyperoxaluria
- (2020) Anna Kletzmayr et al. BIOCONJUGATE CHEMISTRY
- Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat
- (2020) Elisabeth Oppliger Leibundgut et al. HAEMATOLOGICA
- Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
- (2020) Manisha Balwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
- (2020) Timothy Miller et al. NEW ENGLAND JOURNAL OF MEDICINE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates
- (2020) Jesse H. Erasmus et al. Science Translational Medicine
- Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
- (2020) Paul F. McKay et al. Nature Communications
- Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy
- (2020) Oluwayemisi Esan et al. Drug Design Development and Therapy
- Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
- (2020) Karishma Dhuri et al. Journal of Clinical Medicine
- Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
- (2020) Rohit Loomba et al. Lancet Gastroenterology & Hepatology
- Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection
- (2020) Jin Wei et al. CELL
- Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia
- (2020) Daniel Gaudet et al. EUROPEAN HEART JOURNAL
- Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection
- (2020) Gustavo Lou et al. JOURNAL OF CONTROLLED RELEASE
- Paving the Road for RNA Therapeutics
- (2020) Niels Dammes et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Viral Vectors Applied for RNAi-Based Antiviral Therapy
- (2020) Kenneth Lundstrom Viruses-Basel
- Are Viral Vectors Any Good for RNAi Antiviral Therapy?
- (2020) Kenneth Lundstrom Viruses-Basel
- CRISPR-Cas13a Inhibits HIV-1 Infection
- (2020) Lijuan Yin et al. Molecular Therapy-Nucleic Acids
- Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo
- (2020) Eleni Anastasiadou et al. CLINICAL CANCER RESEARCH
- Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion–Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study
- (2020) David P. Steensma et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
- (2020) David Adams et al. LANCET NEUROLOGY
- Clinical Applications of Single-Stranded Oligonucleotides: Current Landscape of Approved and In-Development Therapeutics
- (2020) Juergen Scharner et al. MOLECULAR THERAPY
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced antiviral benefit of combination therapy with anti-HBV and anti-PD1 gRNA/cas9 produces a synergistic antiviral effect in HBV infection
- (2020) Shuai Zhen et al. MOLECULAR IMMUNOLOGY
- Bioconjugated oligonucleotides: recent developments and therapeutic applications
- (2019) sebastien benizri et al. BIOCONJUGATE CHEMISTRY
- Population pharmacokinetic analysis of danvatirsen supporting flat dosing switch
- (2019) Hongmei Xu et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
- (2019) Morgan L. Maeder et al. NATURE MEDICINE
- RNA Modifications Modulate Activation of Innate Toll-Like Receptors
- (2019) Isabel Freund et al. Genes
- IONIS-PKKRx a Novel Antisense Inhibitor of Prekallikrein and Bradykinin Production
- (2019) Jason D. Ferrone et al. Nucleic Acid Therapeutics
- RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial
- (2019) Fatma Doener et al. VACCINE
- Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria
- (2019) Eliane Sardh et al. NEW ENGLAND JOURNAL OF MEDICINE
- The current state and future directions of RNAi-based therapeutics
- (2019) Ryan L. Setten et al. NATURE REVIEWS DRUG DISCOVERY
- mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
- (2019) Giulietta Maruggi et al. MOLECULAR THERAPY
- How mRNA therapeutics are entering the monoclonal antibody field
- (2019) Lien Van Hoecke et al. Journal of Translational Medicine
- Selective tissue targeting of synthetic nucleic acid drugs
- (2019) Punit P. Seth et al. JOURNAL OF CLINICAL INVESTIGATION
- Antisense Inhibition of Glucagon Receptor by IONIS-GCGRRx Improves Type 2 Diabetes Without Increase in Hepatic Glycogen Content in Patients With Type 2 Diabetes on Stable Metformin Therapy
- (2019) Erin S. Morgan et al. DIABETES CARE
- Design of in vitro Transcribed mRNA Vectors for Research and Therapy
- (2019) Marina Tusup et al. CHIMIA
- N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
- (2019) Veronica J Alexander et al. EUROPEAN HEART JOURNAL
- mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
- (2019) Robert A. Feldman et al. VACCINE
- Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis
- (2019) Veena Mathew et al. Drug Design Development and Therapy
- Current Development of siRNA Bioconjugates: From Research to the Clinic
- (2019) Ivan V. Chernikov et al. Frontiers in Pharmacology
- Antisense oligonucleotide eluforsen is safe and improves respiratory symptoms in F508DEL cystic fibrosis
- (2019) Pavel Drevinek et al. Journal of Cystic Fibrosis
- Acute hepatic porphyrias: Current diagnosis & management
- (2019) Karl E. Anderson MOLECULAR GENETICS AND METABOLISM
- iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
- (2019) Wesley de Jong et al. Trials
- Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis
- (2019) Morie A. Gertz et al. Expert Review of Clinical Pharmacology
- Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5
- (2019) Morgan Brisse et al. Frontiers in Immunology
- A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection
- (2019) Nurgun Kose et al. Science Immunology
- Targeted delivery and endosomal cellular uptake of DARPin-siRNA bioconjugates: Influence of linker stability on gene silencing
- (2019) Cornelia Lorenzer et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice
- (2019) Brett W Jagger et al. JOURNAL OF INFECTIOUS DISEASES
- Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
- (2019) Joseph L. Witztum et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity and Protection Efficacy of a Naked Self-Replicating mRNA-Based Zika Virus Vaccine
- (2019) Zifu Zhong et al. Vaccines
- Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections
- (2019) Leroy Versteeg et al. Vaccines
- Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
- (2019) Jinkuk Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- CRISPR-Cas9 modified bacteriophage for treatment of Staphylococcus aureus induced osteomyelitis and soft tissue infection
- (2019) Leah H. Cobb et al. PLoS One
- Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response
- (2019) Sergio Linares-Fernández et al. TRENDS IN MOLECULAR MEDICINE
- Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis
- (2019) Teresa Coelho et al. JOURNAL OF NEUROLOGY
- Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran
- (2019) Pedro Renato de Paula Brandão et al. Molecular Diagnosis & Therapy
- The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
- (2019) Akin Akinc et al. Nature Nanotechnology
- Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
- (2019) Wesley de Jong et al. Trials
- Improved Nucleic Acid Therapy with Advanced Nanoscale Biotechnology
- (2019) Yuhua Weng et al. Molecular Therapy-Nucleic Acids
- Inhibition of hepatitis B virus replication via HBV DNA cleavage by Cas9 from Staphylococcus aureus
- (2018) Yu Liu et al. ANTIVIRAL RESEARCH
- Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine
- (2018) Hyokyoung Kwon et al. BIOMATERIALS
- Lipid Polymer Hybrid Nanomaterials for mRNA Delivery
- (2018) Weiyu Zhao et al. Cellular and Molecular Bioengineering
- Locked nucleic acid: modality, diversity, and drug discovery
- (2018) Peter H. Hagedorn et al. DRUG DISCOVERY TODAY
- Tivanisiran, a novel siRNA for the treatment of dry eye disease
- (2018) Javier Moreno-Montañés et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy
- (2018) Yang Li et al. International Journal of Nanomedicine
- Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy
- (2018) Changmai Chen et al. MEDICINAL RESEARCH REVIEWS
- Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
- (2018) Annette B. Vogel et al. MOLECULAR THERAPY
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-miRNA oligonucleotides: A comprehensive guide for design
- (2018) Joana Filipa Lima et al. RNA Biology
- CRISPR-Cas based antiviral strategies against HIV-1
- (2018) Gang Wang et al. VIRUS RESEARCH
- Inhibition of Human Papillomavirus Type 16 Infection Using an RNA Aptamer
- (2018) Diana Gabriela Valencia-Reséndiz et al. Nucleic Acid Therapeutics
- GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
- (2018) Aaron D. Springer et al. Nucleic Acid Therapeutics
- Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1
- (2018) Jiehua Zhou et al. Theranostics
- Review of CRISPR/Cas9 sgRNA Design Tools
- (2018) Yingbo Cui et al. Interdisciplinary Sciences-Computational Life Sciences
- Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice
- (2018) Ramona Bella et al. Molecular Therapy-Nucleic Acids
- Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b trial
- (2018) Maro Ohanian et al. Lancet Haematology
- Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma
- (2018) Anita G. Seto et al. BRITISH JOURNAL OF HAEMATOLOGY
- Patisiran: First Global Approval
- (2018) Sheridan M. Hoy DRUGS
- Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
- (2018) Norbert Pardi et al. Nature Communications
- CpG Still Rocks! Update on an Accidental Drug
- (2018) Arthur M. Krieg Nucleic Acid Therapeutics
- New Vaccine Technologies to Combat Outbreak Situations
- (2018) Susanne Rauch et al. Frontiers in Immunology
- Engineering nanoparticles for targeted delivery of nucleic acid therapeutics in tumor
- (2018) Yao Xiao et al. Molecular Therapy-Methods & Clinical Development
- Mipomersen and its use in familial hypercholesterolemia
- (2018) Johnathon Seth Parham et al. EXPERT OPINION ON PHARMACOTHERAPY
- DNA Vaccines—How Far From Clinical Use?
- (2018) Dominika Hobernik et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis
- (2018) Isabelle Sermet-Gaudelus et al. Journal of Cystic Fibrosis
- A microRNA-29 mimic (remlarsen) represses extracellular matrix expression and fibroplasia in the skin
- (2018) Corrie L. Gallant-Behm et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy
- (2018) Yiwen Dong et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening
- (2018) Alexandra G. Orlandini von Niessen et al. MOLECULAR THERAPY
- mRNA-Based Protein Replacement Therapy for the Heart
- (2018) Ajit Magadum et al. MOLECULAR THERAPY
- Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
- (2018) Nuphar Veiga et al. Nature Communications
- Molecular basis of primary hyperoxaluria: clues to innovative treatments
- (2018) Mirco Dindo et al. Urolithiasis
- Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral Infections
- (2018) Kumari Asha et al. Journal of Clinical Medicine
- Alicaforsen for the treatment of inflammatory bowel disease
- (2017) Vipul Jairath et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design
- (2017) Timothy Pepini et al. JOURNAL OF IMMUNOLOGY
- Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
- (2017) Martin Alberer et al. LANCET
- Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial
- (2017) Meike H van der Ree et al. LANCET
- In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models
- (2017) Chaoran Yin et al. MOLECULAR THERAPY
- Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation
- (2017) Yating Sun et al. MOLECULES
- Overcoming cellular barriers for RNA therapeutics
- (2017) Steven F Dowdy NATURE BIOTECHNOLOGY
- Mapping the genomic landscape of CRISPR–Cas9 cleavage
- (2017) Peter Cameron et al. NATURE METHODS
- CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR–Cas9 nuclease off-targets
- (2017) Shengdar Q Tsai et al. NATURE METHODS
- Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy
- (2017) David R Corey NATURE NEUROSCIENCE
- Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy
- (2017) K. John Pasi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
- (2017) Xiulong Shen et al. NUCLEIC ACIDS RESEARCH
- Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals
- (2017) Colin J. McKinlay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens
- (2017) Giulietta Maruggi et al. VACCINE
- Eteplirsen in the treatment of Duchenne muscular dystrophy
- (2017) Kenji Rowel Lim et al. Drug Design Development and Therapy
- FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga
- (2017) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues
- (2017) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- Antiviral treatment strategies based on gene silencing and genome editing
- (2017) Roger Badia et al. Current Opinion in Virology
- Advances in the delivery of RNA therapeutics: from concept to clinical reality
- (2017) James C. Kaczmarek et al. Genome Medicine
- Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9
- (2017) Hao Li et al. Frontiers in Cellular and Infection Microbiology
- Induction of Protective Immunity against Toxoplasma gondii in Mice by Nucleoside Triphosphate Hydrolase-II (NTPase-II) Self-amplifying RNA Vaccine Encapsulated in Lipid Nanoparticle (LNP)
- (2017) Fangjun Luo et al. Frontiers in Microbiology
- Quantum Dots-siRNA Nanoplexes for Gene Silencing in Central Nervous System Tumor Cells
- (2017) Guimiao Lin et al. Frontiers in Pharmacology
- Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian Hamsters
- (2017) Katrin Schaar et al. Molecular Therapy-Nucleic Acids
- Antisense Oligonucleotides Promote Exon Inclusion and Correct the Common c.-32-13T>G GAA Splicing Variant in Pompe Disease
- (2017) Erik van der Wal et al. Molecular Therapy-Nucleic Acids
- Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
- (2017) Chiranjib Chakraborty et al. Molecular Therapy-Nucleic Acids
- siRNA Delivery Strategies: A Comprehensive Review of Recent Developments
- (2017) Katyayani Tatiparti et al. Nanomaterials
- The Clinical Application of MicroRNAs in Infectious Disease
- (2017) Ruth E. Drury et al. Frontiers in Immunology
- First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
- (2017) Norbert Pfeiffer et al. PLoS One
- Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides
- (2016) Elizabeth J. Ackermann et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy
- (2016) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27), in patients with castration-resistant prostate cancer and other advanced cancers
- (2016) K. N. Chi et al. ANNALS OF ONCOLOGY
- Editing DNA Methylation in the Mammalian Genome
- (2016) X. Shawn Liu et al. CELL
- CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs
- (2016) Mohammad A. Mandegar et al. Cell Stem Cell
- Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
- (2016) Andres Digenio et al. DIABETES CARE
- A phase I dose escalation, safety and pharmacokinetic (PK) study of AZD5312 (IONIS-ARRx), a first-in-class Generation 2.5 antisense oligonucleotide targeting the androgen receptor (AR)
- (2016) S. Chowdhury et al. EUROPEAN JOURNAL OF CANCER
- Progress and perspective of inorganic nanoparticle-based siRNA delivery systems
- (2016) Ying Jiang et al. Expert Opinion on Drug Delivery
- Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study
- (2016) R Kaminski et al. GENE THERAPY
- Intrathecal Injections in Children With Spinal Muscular Atrophy
- (2016) Manon Haché et al. JOURNAL OF CHILD NEUROLOGY
- Long-term mipomersen treatment is associated with a reduction in cardiovascular events in patients with familial hypercholesterolemia
- (2016) P. Barton Duell et al. Journal of Clinical Lipidology
- Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles
- (2016) Tsukasa Sugo et al. JOURNAL OF CONTROLLED RELEASE
- Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles
- (2016) Srinivas Ramishetti et al. JOURNAL OF DRUG TARGETING
- ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients
- (2016) Jens Gottlieb et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- A Nonarteritic Anterior Ischemic Optic Neuropathy Clinical Trial
- (2016) Mark J. Kupersmith et al. JOURNAL OF NEURO-OPHTHALMOLOGY
- Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus
- (2016) Bin Zhou et al. JOURNAL OF VIROLOGY
- Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
- (2016) Richard S Finkel et al. LANCET
- Use of Single-Chain Antibody Derivatives for Targeted Drug Delivery
- (2016) Yaghoub Safdari et al. MOLECULAR MEDICINE
- Highly efficient siRNA delivery from core–shell mesoporous silica nanoparticles with multifunctional polymer caps
- (2016) Karin Möller et al. Nanoscale
- Applications of CRISPR technologies in research and beyond
- (2016) Rodolphe Barrangou et al. NATURE BIOTECHNOLOGY
- Non-coding RNAs as drug targets
- (2016) Masayuki Matsui et al. NATURE REVIEWS DRUG DISCOVERY
- Repurposing the CRISPR-Cas9 system for targeted DNA methylation
- (2016) Aleksandar Vojta et al. NUCLEIC ACIDS RESEARCH
- Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
- (2016) Diletta Magini et al. PLoS One
- Targeted delivery of CRISPR/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome
- (2016) Shuai Zhen et al. Oncotarget
- Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial
- (2016) Jake Dunning et al. PLOS MEDICINE
- CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections
- (2016) Ferdy R. van Diemen et al. PLoS Pathogens
- Screening of efficient polymers for siRNA delivery in a library of hydrophobically modified polyethyleneimines
- (2016) Wanwan Shen et al. Journal of Materials Chemistry B
- Pseudomonas aeruginosa infection augments inflammation through miR-301b repression of c-Myb-mediated immune activation and infiltration
- (2016) Xuefeng Li et al. Nature Microbiology
- A CRISPR-based approach for targeted DNA demethylation
- (2016) Xingxing Xu et al. Cell Discovery
- Inhibition of HSV-1 Replication by Gene Editing Strategy
- (2016) Pamela C. Roehm et al. Scientific Reports
- Delivery of therapeutic oligonucleotides with cell penetrating peptides
- (2015) Prisca Boisguérin et al. ADVANCED DRUG DELIVERY REVIEWS
- Preclinical and clinical development of siRNA-based therapeutics
- (2015) Gulnihal Ozcan et al. ADVANCED DRUG DELIVERY REVIEWS
- Evolving landscape in the management of transthyretin amyloidosis
- (2015) Philip N. Hawkins et al. ANNALS OF MEDICINE
- Isolation and characterization of 2′-F-RNA aptamers against whole HIV-1 subtype C envelope pseudovirus
- (2015) Grace M. London et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- New paradigms on siRNA local application
- (2015) Meng Pan et al. BMB Reports
- Clinical and Preclinical Pharmacokinetics and Pharmacodynamics of Mipomersen (Kynamro®): A Second-Generation Antisense Oligonucleotide Inhibitor of Apolipoprotein B
- (2015) Richard S. Geary et al. CLINICAL PHARMACOKINETICS
- Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments
- (2015) Yoshiki Sekijima JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin
- (2015) Michela Brazzoli et al. JOURNAL OF VIROLOGY
- Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers
- (2015) Isaac B Hilton et al. NATURE BIOTECHNOLOGY
- Functional annotation of native enhancers with a Cas9–histone demethylase fusion
- (2015) Nicola A Kearns et al. NATURE METHODS
- Rapid progression of familial amyloidotic polyneuropathy
- (2015) David Adams et al. NEUROLOGY
- Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme
- (2015) Norbert Krug et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis
- (2015) Ayalew Tefferi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia
- (2015) Gabriela M. Baerlocher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment
- (2015) Xi Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trans-splicing group I intron targeting hepatitis C virus IRES mediates cell death upon viral infection in Huh7.5 cells
- (2015) Pruksa Nawtaisong et al. VIROLOGY
- Aptamers in Diagnostics and Treatment of Viral Infections
- (2015) Tomasz Wandtke et al. Viruses-Basel
- Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells
- (2015) Hsin-Kai Liao et al. Nature Communications
- Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis
- (2015) Matteo Fassan et al. Oncotarget
- Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection
- (2015) Panpan Hou et al. Scientific Reports
- CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection
- (2015) Hassen S. Wollebo et al. PLoS One
- Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients
- (2014) Meike H. van der Ree et al. ANTIVIRAL RESEARCH
- The Noncoding RNA Revolution—Trashing Old Rules to Forge New Ones
- (2014) Thomas R. Cech et al. CELL
- The Expanding View of RNA and DNA Function
- (2014) Ronald R. Breaker et al. CHEMISTRY & BIOLOGY
- Lomitapide and Mipomersen
- (2014) Daniel J. Rader et al. CIRCULATION
- Inactivation of the Human Papillomavirus E6 or E7 Gene in Cervical Carcinoma Cells by Using a Bacterial CRISPR/Cas RNA-Guided Endonuclease
- (2014) E. M. Kennedy et al. JOURNAL OF VIROLOGY
- Peptides Used in the Delivery of Small Noncoding RNA
- (2014) Ravi S. Shukla et al. MOLECULAR PHARMACEUTICS
- Gold Nanoparticles for Nucleic Acid Delivery
- (2014) Ya Ding et al. MOLECULAR THERAPY
- A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines
- (2014) Luis A Brito et al. MOLECULAR THERAPY
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- Targeted delivery of antisense oligonucleotides to hepatocytes using triantennaryN-acetyl galactosamine improves potency 10-fold in mice
- (2014) Thazha P. Prakash et al. NUCLEIC ACIDS RESEARCH
- HIV-1 Subtype C Unproductively Infects Human Cardiomyocytes In Vitro and Induces Apoptosis Mitigated by an Anti-Gp120 Aptamer
- (2014) Walter R. Lopes de Campos et al. PLoS One
- RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
- (2014) W. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional high-throughput screening identifies the miR-15 microRNA family as cellular restriction factors for Salmonella infection
- (2014) Claire Maudet et al. Nature Communications
- Toxicological and Pharmacokinetic Properties of QPI-1007, a Chemically Modified Synthetic siRNA Targeting Caspase 2 mRNA, Following Intravitreal Injection
- (2014) Elisabeth C.R. Solano et al. Nucleic Acid Therapeutics
- Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases
- (2014) Kavitha Siva et al. Nucleic Acid Therapeutics
- The role of follicular helper T cells and the germinal center in HIV-1 gp120 DNA prime and gp120 protein boost vaccination
- (2014) Kristin Hollister et al. Human Vaccines & Immunotherapeutics
- AAV-Mediated Gene Therapy for Research and Therapeutic Purposes
- (2014) R. Jude Samulski et al. Annual Review of Virology
- Sampling a Biomarker of the Human Immunodeficiency Virus across a Synthetic Nanopore
- (2013) David J. Niedzwiecki et al. ACS Nano
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
- (2013) Luke A. Gilbert et al. CELL
- Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
- (2013) Raul D. Santos et al. EUROPEAN HEART JOURNAL
- MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment
- (2013) Anca Dorhoi et al. JOURNAL OF CLINICAL INVESTIGATION
- Nucleolin Interacts with the Dengue Virus Capsid Protein and Plays a Role in Formation of Infectious Virus Particles
- (2013) C. A. Balinsky et al. JOURNAL OF VIROLOGY
- Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
- (2013) Teresa Coelho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of HCV Infection by Targeting MicroRNA
- (2013) Harry L.A. Janssen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system
- (2013) David Bikard et al. NUCLEIC ACIDS RESEARCH
- Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
- (2013) Hirotaka Ebina et al. Scientific Reports
- DNA vaccines
- (2013) Cevayir Coban et al. Human Vaccines & Immunotherapeutics
- Potent Inhibition of HIV-1 Reverse Transcriptase and Replication by Nonpseudoknot, “UCAA-motif” RNA Aptamers
- (2013) Angela S Whatley et al. Molecular Therapy-Nucleic Acids
- Gene Silencing Activity of siRNA Molecules Containing Phosphorodithioate Substitutions
- (2012) Xianbin Yang et al. ACS Chemical Biology
- Preventing the formation of positive transcription elongation factor b by human cyclin T1-binding RNA aptamer for anti-HIV transcription
- (2012) Hyun-Ju Um et al. AIDS
- SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity
- (2012) Takanori Kubo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effects of diamond-FET-based RNA aptamer sensing for detection of real sample of HIV-1 Tat protein
- (2012) A. Rahim Ruslinda et al. BIOSENSORS & BIOELECTRONICS
- RNA-Based Therapeutics: Current Progress and Future Prospects
- (2012) John C. Burnett et al. CHEMISTRY & BIOLOGY
- PLGA-based nanoparticles: An overview of biomedical applications
- (2012) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Nonviral delivery of self-amplifying RNA vaccines
- (2012) A. J. Geall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA
- (2012) Nathan M Belliveau et al. Molecular Therapy-Nucleic Acids
- Strand Invasion of Mixed-Sequence, Double-Helical B-DNA by γ-Peptide Nucleic Acids Containing G-Clamp Nucleobases under Physiological Conditions
- (2011) Srinivas Rapireddy et al. BIOCHEMISTRY
- Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid
- (2011) Hiroto Hatakeyama et al. BIOMATERIALS
- The packaging of siRNA within the mesoporous structure of silica nanoparticles
- (2011) Xu Li et al. BIOMATERIALS
- Analysis of the host microRNA response toSalmonellauncovers the control of major cytokines by thelet-7family
- (2011) Leon N Schulte et al. EMBO JOURNAL
- Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation
- (2011) M Diken et al. GENE THERAPY
- Chemical modification and design of anti-miRNA oligonucleotides
- (2011) K A Lennox et al. GENE THERAPY
- Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
- (2011) Anne C. Goldberg et al. Journal of Clinical Lipidology
- Inhibition of Dengue Virus Infections in Cell Cultures and in AG129 Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence
- (2011) D. A. Stein et al. JOURNAL OF VIROLOGY
- Palmitic Acid-Conjugated 21-Nucleotide siRNA Enhances Gene-Silencing Activity
- (2011) Takanori Kubo et al. MOLECULAR PHARMACEUTICS
- CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
- (2011) Elitza Deltcheva et al. NATURE
- Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
- (2011) Yimin Hua et al. NATURE
- Silencing of microRNA families by seed-targeting tiny LNAs
- (2011) Susanna Obad et al. NATURE GENETICS
- Synthesis and biological activity of phosphonoacetate- and thiophosphonoacetate-modified 2′-O-methyl oligoribonucleotides
- (2011) Richard N. Threlfall et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- A Novel Ribozyme-Based Prophylaxis Inhibits Influenza A Virus Replication and Protects from Severe Disease
- (2011) Julie Motard et al. PLoS One
- Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
- (2011) M. A. Passini et al. Science Translational Medicine
- Label Free Inhibitor Screening of Hepatitis C Virus (HCV) NS5B Viral Protein Using RNA Oligonucleotide
- (2011) Changhyun Roh et al. SENSORS
- RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
- (2010) C. Frank Bennett et al. Annual Review of Pharmacology and Toxicology
- Genetic determinants of plasma triglycerides
- (2010) Christopher T. Johansen et al. JOURNAL OF LIPID RESEARCH
- The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination
- (2010) Daphna Nachmani et al. NATURE IMMUNOLOGY
- Riboswitches: Structures and Mechanisms
- (2010) A. D. Garst et al. Cold Spring Harbor Perspectives in Biology
- Multilayer fluorescence optically encoded beads for protein detection
- (2009) Bong-Hyun Jun et al. ANALYTICAL BIOCHEMISTRY
- The Structural and Functional Diversity of Metabolite-Binding Riboswitches
- (2009) Adam Roth et al. Annual Review of Biochemistry
- Exploring Chemical Modifications for siRNA Therapeutics: A Structural and Functional Outlook
- (2009) Siddharth Shukla et al. ChemMedChem
- DNA vaccines for biodefense
- (2009) Lesley C Dupuy et al. Expert Review of Vaccines
- Induction of microRNA‐155 duringHelicobacter pyloriInfection and Its Negative Regulatory Role in the Inflammatory Response
- (2009) Bin Xiao et al. JOURNAL OF INFECTIOUS DISEASES
- Targeted Delivery of Small Interfering RNA to Human Dendritic Cells To Suppress Dengue Virus Infection and Associated Proinflammatory Cytokine Production
- (2009) S. Subramanya et al. JOURNAL OF VIROLOGY
- Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
- (2009) Justin P Dassie et al. NATURE BIOTECHNOLOGY
- MicroRNA-mediated species-specific attenuation of influenza A virus
- (2009) Jasmine T Perez et al. NATURE BIOTECHNOLOGY
- Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells
- (2009) Ronald T Mitsuyasu et al. NATURE MEDICINE
- Unique quadruplex structure and interaction of an RNA aptamer against bovine prion protein
- (2009) T. Mashima et al. NUCLEIC ACIDS RESEARCH
- Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells
- (2009) Jiehua Zhou et al. NUCLEIC ACIDS RESEARCH
- Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
- (2009) R. E. Lanford et al. SCIENCE
- Antisense Masking of an hnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic Mice
- (2008) Yimin Hua et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Distinct Uptake Routes of Cell-Penetrating Peptide Conjugates
- (2008) Per Lundin et al. BIOCONJUGATE CHEMISTRY
- Tumor Regression in Mice by Delivery of Bcl-2 Small Interfering RNA with Pegylated Cationic Liposomes
- (2008) Satoru Sonoke et al. CANCER RESEARCH
- A Simple Cytosine to G-Clamp Nucleobase Substitution Enables Chiral γ-PNAs to Invade Mixed-Sequence Double-Helical B-form DNA
- (2008) Venugopal Chenna et al. CHEMBIOCHEM
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- Inhibition of human immunodeficiency virus-1 entry using vectors expressing a multimeric hammerhead ribozyme targeting the CCR5 mRNA
- (2008) R. Nazari et al. JOURNAL OF GENERAL VIROLOGY
- VEGF siRNA Delivery System Using Arginine-Grafted Bioreducible Poly(disulfide amine)
- (2008) Sun Hwa Kim et al. MOLECULAR PHARMACEUTICS
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
- Potent inhibition of microRNA in vivo without degradation
- (2008) Scott Davis et al. NUCLEIC ACIDS RESEARCH
- Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target
- (2008) D. Peer et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started